BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #1870Drug Manufacturers - Specialty & Generic
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-39.1x
CheapRich

Near the bottom of its 5-year range · 20th percentile, 5-year average 84.2x

Price / book5.8x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 2.1x

#4535 of 5330 stocks by PB (1 = cheapest)

Price / sales7.1x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 3.0x

#4279 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-399x368x1,135x1,903xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$32.15
Price vs. fair value-11.0%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.81 – 2.10 100% (pricier than usual) #4535 of 5330 (1 = cheapest)
PE -39.11 80.30 84.23 20% (cheaper than usual) –
PS 7.14 2.63 3.03 100% (pricier than usual) #4279 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on SUPN.

Sign in to join the discussion.

Scroll to Top